Fact-checked by Grok 2 weeks ago

Polyglycolide

Polyglycolide (), also known as polyglycolic acid, is a biodegradable, and the simplest linear, aliphatic derived from the of , with the repeating unit (–O–CH₂–CO–). It exhibits high crystallinity (typically 40–55%), a melting point of 223–230 °C, a temperature of 35–44 °C, and a of approximately 1.53 g/mL, rendering it insoluble in most common solvents but soluble in hexafluoroisopropanol. Due to its hydrolytic degradability into non-toxic metabolites that are naturally processed by the body, PGA is prized for biomedical applications, where it fully degrades within 6–12 months without eliciting significant inflammatory responses. PGA is primarily synthesized through the (ROP) of glycolide, the cyclic dimer of , using catalysts such as stannous octoate at temperatures of 195–230 °C, which allows for control over molecular weight and enables production of high-molar-mass variants essential for strength. Alternative methods include direct polycondensation of or solid-state polycondensation of halogenoacetates, though ROP remains the most efficient for biomedical-grade material. Its properties, including a of about 7 GPa, make it suitable for load-bearing implants, while its has been validated through extensive animal and studies. In medical contexts, PGA is most notably employed in absorbable sutures (e.g., Dexon and Surgicryl), self-reinforced implants for fixation and osteotomies since the 1980s, scaffolds, and controlled systems, eliminating the need for secondary removal surgeries and reducing risks associated with permanent devices. Degradation occurs via bulk , accelerated in physiological environments, yielding that is metabolized through the tricarboxylic acid cycle, with complete absorption typically in 6–12 months. Emerging applications extend to composites with carbon nanotubes or copolymers with polylactide for enhanced scaffolds in bone regeneration, as well as industrial uses in oil and gas and packaging, with market growth driven by sustainability demands as of 2025. The development of traces back to early patents in for its synthesis, with significant advancements in the through work by Higgins, Schmitt et al., and May & Polistina, leading to the first FDA-approved synthetic absorbable suture in the late and routine clinical use in by 1984. These milestones underscore PGA's evolution from a curiosity to a cornerstone of resorbable biomaterials, driven by its balance of strength, safety, and environmental compatibility.

Structure and properties

Chemical structure

Polyglycolide (PGA) is a linear aliphatic polyester composed of repeating units derived from glycolic acid, with the general formula [- \ce{O-CH2-C(O)} - ]_n. This simple structure consists of ester linkages alternating with methylene groups, making it the simplest member of the poly(α-hydroxy acid) family. The symmetry of the glycolic acid monomer, lacking chiral centers, results in highly regular polymer chains that facilitate close packing and high crystallinity. The for typical high-molecular-weight ranges from approximately 300 to 2,000 units, yielding number-average molecular weights of 20,000–150,000 g/mol. These values are achieved through controlled processes that minimize chain termination, enabling the formation of robust, processable materials. The inherent regularity of the chains, due to the achiral and symmetric , imparts isotactic-like stereoregularity, enhancing the polymer's ability to form ordered crystalline domains without stereochemical defects. PGA exhibits a crystalline with an orthorhombic containing two antiparallel chains, characterized by dimensions a = 5.22 Å, b = 6.19 Å, and c = 7.02 Å (along the fiber axis). The chains adopt a planar zigzag conformation, with groups oriented to promote tight intermolecular packing and a calculated density of about 1.69 g/cm³. This architecture underscores PGA's high thermal stability and mechanical strength. The polymer's formation via polycondensation of glycolic acid can be overviewed by the equation: n \, \ce{HO-CH2-COOH} \rightarrow \ce{[-O-CH2-CO-]_n} + (n-1) \, \ce{H2O} This representation highlights the elimination of water to build the ester backbone, though practical synthesis often involves the cyclic dimer glycolide as a precursor for higher molecular weights.

Physical and thermal properties

Polyglycolide (PGA) exhibits a density of 1.50 g/cm³ in its amorphous form, increasing to 1.707 g/cm³ in the fully crystalline state due to enhanced packing efficiency. This variation reflects its typical crystallinity of 45-55%, which stems from the regular -[O-CH₂-CO]- repeat unit allowing ordered chain alignment. The material demonstrates high mechanical performance, with drawn fibers achieving tensile strengths up to 89 MPa and a Young's modulus of approximately 7 GPa, attributes largely attributable to its crystalline domains. Thermally, PGA has a glass transition temperature (Tg) of 35-40°C, marking the onset of segmental mobility in the amorphous regions, and a of 220-230°C, indicative of strong intermolecular forces in the crystalline lattice. It maintains thermal stability up to about 250°C, beyond which decomposition initiates through random chain scission, releasing monomers and oligomers. PGA shows limited solubility, dissolving primarily in highly fluorinated solvents such as hexafluoroisopropanol, while remaining insoluble in and most common organic solvents like alcohols and hydrocarbons. Optically, thin films of PGA are transparent, with a around 1.5, making it suitable for applications requiring clarity in biomedical contexts.

Synthesis

Ring-opening polymerization

The (ROP) of glycolide, a six-membered cyclic diester derived from , serves as the primary route for producing high-molecular-weight polyglycolide in both laboratory and industrial settings. This method enables the formation of well-defined polyesters with tailored properties suitable for biomedical and material applications. The proceeds via a coordination-insertion , where stannous octoate ((Oct)₂) acts as the catalyst and an (ROH) serves as the initiator, facilitating acyl-oxygen cleavage of the glycolide ring. The overall reaction can be represented as: n \ \ce{(glycolide)} + \ce{ROH} \rightarrow \ce{RO-[CO-CH2-O]_n-H} + \text{byproducts} This process typically occurs in bulk or solution at temperatures of 150–200°C under an inert atmosphere, such as , to prevent oxidative degradation and achieve high . Resulting polymers exhibit high molecular weights (M_w > 100,000 g/mol) and narrow polydispersity indices (PDI ≈ 1.5–2.0), reflecting the controlled of the chain growth. Key advantages of this ROP include high yields (90–95%) and precise control over end-group functionality, which allows for post-polymerization modifications like conjugation to bioactive molecules. The method was first reported in 1954 by et al. for fiber production, marking an early milestone in developing strong, processable polyglycolide materials. Variations of the standard Sn(Oct)₂-mediated process include anionic initiation, often using alkoxides for living polymerization with enhanced stereocontrol, or cationic initiation with acids for specific microstructural tuning.

Polycondensation methods

Polycondensation methods for synthesizing polyglycolide (PGA) involve the step-growth reaction of glycolic acid monomers, providing a straightforward route that avoids the need for cyclic monomer preparation, though it generally results in polymers with inferior molecular weight control compared to ring-opening polymerization. These methods are particularly valued for their simplicity in laboratory settings and adaptability for incorporating modifications during synthesis. Direct polycondensation entails heating glycolic acid under reduced pressure to facilitate dehydration and ester linkage formation. Typical procedures involve initial heating at 175–185°C under atmospheric pressure, followed by vacuum application (e.g., 70–150 Pa) at 180–220°C for several hours to shift the equilibrium by removing water via multi-stage distillation, thereby minimizing hydrolysis. Catalysts such as tin(II) chloride or zinc acetate are commonly employed to accelerate the reaction, with the overall process represented by the equation: n \ \ce{HO-CH_2-COOH} \rightarrow \left[-\ce{O-CH_2-CO}-\right]_n + (n-1) \ \ce{H_2O} This approach yields PGA with molecular weights typically in the range of 10,000–50,000 g/mol and polydispersity indices greater than 3, owing to equilibrium limitations and incomplete water removal. Despite its accessibility, direct polycondensation is hindered by side reactions, such as ether bond formation via alternative dehydration pathways, which compromise chain regularity and thermal stability. Yields generally range from 70–85%, rendering the method suitable for small-scale production or the preparation of copolymers and modified PGAs where high molecular weight is not essential. An indirect polycondensation route proceeds via initial formation of low-molecular-weight oligo(glycolic acid) prepolymers through condensation under conditions similar to the direct method (e.g., 170–190°C with catalysts), followed by thermal degradation of these oligomers at 230–290°C under vacuum to generate the glycolide intermediate. This depolymerization step, often conducted in the presence of polar solvents or hydroxyl-containing compounds to stabilize the process, enables subsequent polymerization while leveraging the initial condensation for monomer derivation. Challenges include accumulation of impurities like diglycolic acid during degradation, which can lower glycolide purity and overall efficiency.

Degradation

Hydrolytic degradation

Hydrolytic degradation of polyglycolide proceeds through the random, non-enzymatic cleavage of ester linkages along its polymer backbone, a process inherent to its biodegradability in aqueous environments. This mechanism involves nucleophilic attack by water molecules on the carbonyl groups of the ester bonds, leading to chain scission without the involvement of biological enzymes. The reaction is autocatalyzed by carboxylic acid end-groups generated as degradation progresses, which lower the local pH and accelerate further hydrolysis. Polyglycolide exhibits bulk erosion during hydrolytic , where water penetrates the entire , resulting in uniform chain cleavage before significant mass loss occurs. Under standard conditions ( 7.4, 37°C), mass loss occurs over several weeks, with the rate depending on the form and conditions; significant is typically observed within 2-6 weeks for many forms, though the rate increases at lower due to enhanced . The degradation kinetics follow a first-order model, with the rate constant given by the : k = A e^{-E_a / RT} where E_a is approximately 50-60 kJ/mol, A is the pre-exponential factor, R is the gas constant, and T is the absolute temperature. Several factors influence the hydrolytic degradation rate of polyglycolide. Higher crystallinity impedes initial water diffusion and slows degradation, with amorphous regions hydrolyzing preferentially; as degradation advances, crystallinity may transiently increase due to selective removal of disordered chains. Molecular weight inversely correlates with the degradation rate, as lower initial molecular weight facilitates faster chain scission and product diffusion; degradation rates are also influenced by processing methods like fiber orientation, which affect water diffusion. The ester bonds in the -[O-CH₂-CO]- repeating units provide the primary sites for hydrolysis. The primary products of hydrolytic degradation are glycolic acid monomers and soluble oligomers, which can further hydrolyze to yield additional monomers. Testing methods for characterizing this process include to quantify mass loss over time, (GPC) to track reductions in molecular weight, and (NMR) spectroscopy to monitor the extent of chain scission and oligomer formation.

Biodegradation processes

In vivo, polyglycolide (PGA) undergoes initial hydrolysis to glycolic acid, which is then metabolized through the Krebs cycle and ultimately excreted as carbon dioxide and water via respiration and urine. This process ensures complete bioresorption, with PGA exhibiting a half-life of approximately 2 weeks to 6 months in human tissue, leading to full degradation typically within 4-12 months, depending on the implant form, location, and molecular weight. While some enzymatic activity from esterases may contribute, the degradation is predominantly non-enzymatic hydrolysis under physiological conditions, making PGA particularly suitable for biomedical implants where controlled resorption is desired. In environmental settings, PGA demonstrates rapid biodegradation in soil and compost environments, achieving complete mineralization within 3-6 months under aerobic conditions, as evaluated by standards such as ISO 14855. Microorganisms, particularly Bacillus species, play a key role by producing extracellular esterases that hydrolyze PGA into glycolic acid, which is then assimilated as a carbon source for microbial growth. This microbial consortium facilitates chain scission and ultimate conversion to CO₂, water, and biomass, with degradation profiles comparable to cellulose in compost systems. Recent studies (as of 2024) have explored modifications to further enhance PGA biodegradation in marine and compost environments. Several factors influence PGA biodegradation rates, including , temperature, and microbial density. Optimal degradation occurs at neutral to slightly alkaline (around 7-8) and temperatures of 37°C for processes or 50-60°C in composting, where higher microbial activity predominates; acidic conditions can slow but may autocatalyze in localized environments. Increased microbial density enhances enzymatic attack, while copolymers such as poly(lactic-co-glycolic acid) () typically exhibit slower rates due to the incorporation of hydrophobic units that reduce water uptake and accessibility to degraders. PGA degradation products, primarily , are non-toxic and readily metabolized, posing minimal systemic risk. However, during rapid , accumulation of acidic byproducts can lower local , potentially inducing through complement activation and immune cell recruitment at implantation sites.

Applications

Biomedical applications

(), valued for its and rapid biodegradability, has been extensively employed in biomedical applications, particularly for temporary implants that eliminate the need for secondary removal surgeries. Its first major commercial use was in absorbable sutures, such as Dexon, introduced in the 1970s following FDA approval for medical devices. These sutures retain approximately 50% of their initial tensile strength after 2 weeks and lose nearly all strength by 4 weeks, while complete resorption occurs in 60-90 days through hydrolytic degradation into non-toxic metabolites. In orthopedics, serves as a material for fixation devices, including self-reinforced pins, rods, and screws, which provide during and are fully resorbed without requiring explantation. Clinical studies have demonstrated successful application in treating s and osteotomies since the , with resorption typically completing in 6-12 months, though rare cases of transient formation (1.7%) may occur without impacting overall . For , scaffolds, often fabricated via to achieve high (80-90%) and interconnected pore structures, bone and cartilage regeneration by facilitating , , and extracellular matrix deposition. PGA also enables through microspheres designed for controlled release of therapeutics like antibiotics or proteins, where blending with other polymers minimizes initial burst release and extends delivery profiles over weeks. Systems analogous to PLGA-based formulations, such as those for leuprolide acetate (e.g., Lupron Depot), leverage PGA's tunable degradation for sustained dosing. Recent advancements in the include 3D-printed PGA-based implants for personalized orthopedic and regenerative applications, enhancing precision in scaffold design for complex defects. As of 2025, the global PGA market is projected at USD 5.55 billion, with ongoing research into 3D-printed PLA/PGA composites for enhanced bone scaffolds. Despite these benefits, PGA's rapid can produce acidic byproducts that induce transient local or pH drops, potentially complicating applications requiring prolonged mechanical integrity.

Industrial applications

Polyglycolide (), known for its high crystallinity and mechanical strength, finds significant industrial applications beyond , particularly in sustainable manufacturing where its biodegradability and barrier properties enable eco-friendly alternatives to petroleum-based materials. In packaging, PGA is utilized for biodegradable films and bottles, leveraging its exceptional oxygen barrier properties to extend for beverages and toiletries. The material exhibits an oxygen transmission rate below 1 cm³·mm/m²·day·atm, making it superior among biodegradable polyesters for preserving and reducing waste. For fibers and textiles, high-strength yarns are employed in industrial applications such as filters and geotextiles, where their toughness and abrasion resistance provide reinforcement while degrading naturally in environmental conditions. In , PGA fibers typically degrade within 6-12 months under aerobic composting or burial, facilitating temporary uses like without long-term residue. In oil and gas recovery, serves as a key material for sacrificial plugs in hydraulic fracturing operations, where it hydrolyzes in downhole fluids to enhance well permeability and eliminate the need for mechanical removal. These degradable plugs, such as those developed by Kureha under the Kureha Degradable Plug (KDP), dissolve controllably, improving operational efficiency in extraction. PGA also acts as a in composites, particularly when blended with (), to boost mechanical performance for sustainable structural materials. Incorporating PGA fibers into PLA matrices can significantly increase tensile and , with reports of up to several-fold improvements depending on fiber content. Recent developments since 2014 have focused on high-molecular-weight PGA production, led by Kureha Corporation, enabling scalable manufacturing for sustainable plastics that reduce reliance on fossil fuels in packaging and industrial components. This industrial process yields PGA with improved processability and properties, supporting broader adoption in eco-materials. The global PGA market reflects growing industrial demand, with production capacity exceeding 45,000 metric tons annually as of 2025, driven by a of approximately 9-10% fueled by initiatives.

History

Discovery and early research

The discovery of polyglycolide, also known as polyglycolic acid (PGA), traces back to the early 1950s when researchers at E.I. du Pont de Nemours and Company synthesized the polymer through polycondensation of hydroxyacetic acid, initially targeting applications in synthetic fibers due to its toughness and fiber-forming properties. This work included explorations of (ROP) methods in the early 1950s, though early efforts yielded polymers with limited molecular weight suitable primarily for non-medical uses. A pivotal early patent, granted in 1954 to N.A. Higgins of , detailed the preparation of high-molecular-weight polymers from hydroxyacetic acid, establishing the foundational route for and highlighting its potential as a material. However, studies quickly identified hydrolytic instability as a major challenge, causing rapid degradation in moist environments and restricting PGA to short-term or controlled applications. In the 1960s, research shifted toward biomedical potential when Company investigated for absorbable sutures, addressing the need for materials that could eliminate suture removal surgeries. This effort, led by figures like Edward E. Schmitt, culminated in the development of the first synthetic absorbable sutures around 1962. By 1970, extensive animal studies had confirmed 's , with the showing complete resorption within months without significant , paving the way for its surgical adoption.

Commercial development

The commercialization of polyglycolide (PGA) began in the medical sector, driven by its potential as a biodegradable material for surgical applications. In the late 1960s, , through its subsidiary Davis & Geck, developed and patented processes for producing high-molecular-weight PGA suitable for sutures, building on earlier work including U.S. Patent 3,297,033 by Schmitt and Polistina in 1967, which outlined its use in surgical elements. The company introduced Dexon, the first synthetic absorbable PGA suture, to the market in 1970, marking a significant advancement over traditional sutures due to its predictable degradation and reduced tissue reaction. Commercial production facilities in , were operational by 1970, enabling widespread adoption in , , and gynecology. Following the success of Dexon, which established PGA as a standard for resorbable sutures, further refinements focused on copolymers like poly(glycolide-co-lactide) to tailor degradation rates, though pure remained central to early products. By the , -based medical devices expanded to include meshes and staples, with (later acquired by other firms) continuing production. In the 2000s, commercialization extended beyond to industrial applications, led by Kureha Corporation in . Kureha announced the world's first industrial-scale manufacturing process for high-molecular-weight in , investing over $100 million in a commercial plant in Belle, West Virginia, , with production starting in 2010, to produce materials for oilfield sealing, barriers, and due to PGA's high strength and gas permeability. This development addressed previous limitations in scalability and cost, enabling annual production capacities of 4,000 metric tons and broadening market applications. By 2014, Kureha achieved full commercial viability for these non-medical uses. As of 2023, Kureha expanded its PGA production capacity in to meet growing demand in and biomedical applications, contributing to the global PGA market's projected growth to over $1 billion by 2030.

References

  1. [1]
    Polyglycolide inherent viscosity 1.4dL/g 26124-68-5
    ### Summary of Polyglycolide (Product #457620)
  2. [2]
    Polyglycolide - an overview | ScienceDirect Topics
    Polyglycolide (PGA) is a hydrolytically degradable, thermoplastic, highly crystalline polymer (roughly 40–50% in crystallinity) most widely noted for its use in ...
  3. [3]
    Absorbable polyglycolide devices in trauma and bone surgery
    Poly(glycolic acid) or polyglycolide (PGA) is a polymer of glycolic acid. Glycolic acid is produced during normal body metabolism and is known as ...
  4. [4]
    A review on synthesis and biomedical applications of polyglycolic acid
    Jul 12, 2020 · This review summarizes the different synthesis pathways and physicochemical properties of PGA. Biomedical applications of PGA are also discussed.
  5. [5]
    Structural Evolution of Polyglycolide and Poly(glycolide-co-lactide ...
    Oct 19, 2021 · It was found that the PGA fiber was more susceptible to the degradation process than the P(GA-co-LA) fiber and a higher heat-setting temperature reduced the ...
  6. [6]
    Polyglycolic Acid (PGA) - MatWeb
    This is a biodegradable polymer. It has been used in medical procedures as a wound closure material. It is generally formed and used with high crystallinity.Missing: 5.25 7.64 7.08
  7. [7]
    Crystal Modulus of Poly(glycolic acid) and Its Temperature ...
    The mechanical properties of PGA are regraded to be comparable to PEEK, showing a tensile strength of ~100 MPa, a Young's modulus ~7 GPa, a flexural strength ...
  8. [8]
    The effects on thermal stability of polyglycolic acid by adding ...
    Due to low thermal stability at 255 °C close to melting point (about 220–230 °C) [9], quantitative decomposition will occur during the processing and various ...
  9. [9]
    Poly(glycolide) multi-arm star polymers: Improved solubility via ... - NIH
    Jun 21, 2010 · ... repeat unit. The first glycolic acid repeat unit, directly attached to the PG core, is represented by two different signals: H (4.78 ppm) or ...
  10. [10]
    Controlled Ring-Opening Polymerization of Lactide and Glycolide
    In practice, appropriate polymerization conditions allow for the controlled ROP of lactide and glycolide, and the mean degree of polymerization (DP) of the ...
  11. [11]
    Synthesis of Poly(Lactic Acid-co-Glycolic Acid) Copolymers ... - MDPI
    Jul 26, 2021 · ... ring-opening polymerisation of d-l-lactide (L) and glycolide (G), using tin 2-ethylhexanoate (Sn(Oct)2) as the catalyst and 1-dodecanol as ...
  12. [12]
  13. [13]
    Living/Controlled Anionic Polymerization of Glycolide in ...
    Jun 29, 2023 · As a representative example, a low-molecular-weight PGA was directly recycled at 220 °C, under vacuum (∼10 mbar) in 5 min without a catalyst ( ...<|separator|>
  14. [14]
    Structure‐Processing‐Property Relationship of Poly(Glycolic Acid ...
    Dec 9, 2010 · Two macromolecular chains pass through the orthorhombic unit cell of dimensions a = 5.22 ... Crystal structure of polyglycolide, Die ...
  15. [15]
    Melt/solid polycondensation of glycolic acid to obtain high-molecular ...
    Ordinary melt polycondensation of GA gives a low-molecular-weight oligomer, which likely decomposes into glycolide to prevent the chain-growth of PGA. This is ...
  16. [16]
    Glycolide production process, and glycolic acid oligomer for ...
    The present invention relates generally to a process for the production of glycolide that is a cyclic dimer ester of glycolic acid.
  17. [17]
    Synthesis of glycolide by catalytic depolymerization of glycolic acid ...
    This research is devoted to the synthesis of glycolide by depolymerization of glycolic acid oligomers modified by polyhydric alcohols
  18. [18]
  19. [19]
  20. [20]
    Biocompatibility, biodegradation and biomedical applications of poly ...
    Apr 16, 2019 · This review provides an overview of the biocompatibility and biodegradation of PLA, PLGA and their copolymers, with a special emphasis on tissue responses for ...
  21. [21]
    Poly(glycolic acid) (PGA): a versatile building block expanding high ...
    PGA is rapidly biodegradable and 100% compostable, showing a similar biodegradation profile to cellulose.
  22. [22]
    Bacillus pumilus B12 Degrades Polylactic Acid and ... - NIH
    This degradation can be detected on a short timescale, with significant degradation detected within 48-h by the release of L-lactate monomers, allowing for a ...Missing: polyglycolic compost
  23. [23]
    Degradation Behaviors of Polylactic Acid, Polyglycolic Acid ... - NIH
    Jun 21, 2024 · The results indicated that the addition of PLA slowed down the degradation rate of PGA ... polyglycolide, polylactide, and poly(lactide-co ...
  24. [24]
    Polyglycolic acid induced inflammation: Role of hydrolysis and ...
    PGA can induce a local inflammatory response following implantation, so we investigated the molecular mechanism of inflammation in vitro and in vivo.Missing: toxic | Show results with:toxic
  25. [25]
    Biomedical Applications of Biodegradable Polymers - PMC
    Polyglycolide or poly(glycolic acid) (PGA) was one of the very first degradable polymers ever investigated for biomedical use. With a melting point (Tm) greater ...
  26. [26]
    Absorbable polyglycolide devices in trauma and bone surgery
    Strong implants can be manufactured from this polymer with a self-reinforcing (SR) technique and used in the treatment of fractures and osteotomies.
  27. [27]
    Morphological and biomechanical characterization of poly(glycolic ...
    Poly(glycolic acid) (PGA) fibrous nonwoven scaffolds have been used to engineer a variety of tissue, such as cartilage, bone [3], [4], [5], [6], [7]. To better ...
  28. [28]
    Patient-specific implants made of 3D printed bioresorbable polymers ...
    Apr 19, 2024 · This study shows the feasibility of using 3D printing to create degradable polymeric PSIs seamlessly integrated into virtual surgical planning workflows.
  29. [29]
    Product Groups - PGA - Kureha America
    Kureha's PGA (polyglycolic acid) resin Kuredux offers advanced characteristics ... extraction and industrial processes, as well as packaging materials.Missing: fibers oil composites
  30. [30]
    Challenges and new opportunities on barrier performance of ...
    Poly (glycolic acid) (PGA) or polyglycolide is an attracting biodegradable polymer for packaging application, due to its highest oxygen/water barrier among all ...
  31. [31]
    Biodegradation behavior of poly (glycolic acid) (PGA) and poly ...
    Jul 24, 2024 · In addition, previous studies have shown that the degradation time of PGA is relatively short, ranging from about 1.5 to 3 months in an open ...
  32. [32]
    PGA increases efficiency of drilling process
    As the process is repeated, frac plugs are used to temporarily close the horizontal shaft to prevent water pressure from escaping into the crack created in the ...Missing: sacrificial | Show results with:sacrificial
  33. [33]
    [PDF] Degradation Study on Materials for Dissolvable Frac Plugs - Kuredux
    Two types of DFPs, polyglycolic acid (PGA) DFPs and Mg alloy DFPs, are widely used. Both types of DFPs can degrade, dissolve, or disintegrate in fluids used in ...Missing: sacrificial | Show results with:sacrificial
  34. [34]
    (PDF) Mechanical Properties and Bioactivity of Poly(Lactic Acid ...
    Oct 15, 2025 · The tensile and flexural strength of PLA/HA-g-PLA composites were increased compared with those of PLA/HA, apparently due to the better ...
  35. [35]
    Study on 3D printing process of continuous polyglycolic acid fiber ...
    A continuous polyglycolic acid (PGA) fiber-reinforced polylactic acid (PLA) degradable composite was proposed for application in biodegradable load-bearing ...Missing: polyglycolide | Show results with:polyglycolide
  36. [36]
    Development of an industrial production technology for high ... - Nature
    Aug 6, 2014 · In this method, the ring-opening polymerization of GL is achieved within the temperature range between the melting point of GL (∼90 °C) and the ...
  37. [37]
    Polyglycolic Acid (PGA) Resin Market Size, Share & Forecast Report ...
    Global production of PGA resin surpassed 45,000 metric tons in 2025, showing a 26% increase from 2023. Its high mechanical strength (tensile strength exceeding ...
  38. [38]
    Polyglycolic Acid (PGA) Market Size & Outlook, 2025-2033
    The global polyglycolic acid (PGA) market size is projected to grow from USD 5.55 billion in 2025 to USD 11.11 billion by 2033, exhibiting a CAGR of 9.07%.Missing: tons | Show results with:tons
  39. [39]
    US2676945A - Condensation polymers of hydroxyacetic acid
    This invention relates to condensation polymers of hydroxyacetic acid, and relates more particularly to a new plastic material, polyhydroxyacetic ester, ...Missing: Schneider | Show results with:Schneider
  40. [40]
    Biodegradable polymers for use in surgery—polyglycolic/poly(actic ...
    Details of the synthesis of PGA and PLA polymers from their cyclic diesters are described, as well as a series of glycolide/lactide copolymers.
  41. [41]
    Davis and Geck - Syracuse University Libraries Digital Collections
    ... suture (Dexon), introduced in the 1970s. It consisted of a man-made organic material, polyglycolic acid. In the 1950s the American Cyanamid subsidiary moved ...
  42. [42]
    A Synthetic Suture Called Compatible With Human Tissue
    Jul 5, 1970 · Cyanmid spokesmen described Dexon as a glycolate and said they believed it was more compatible than sutures made from animal gut because ...Missing: history | Show results with:history
  43. [43]
    [PDF] American Cyanamid Company - Toxic Docs
    Facilities for the commercial production of Dex o n sutures are under construction at the plant in Danbury,. Connecticut, with completion expected in 1970.
  44. [44]
    American Cyanamid - an overview | ScienceDirect Topics
    American Cyanamid is defined as a company known for producing Dexon, a resorbable suture made from polyglycolic acid (PGA), which is utilized in tissue ...Missing: polyglycolide 1960s
  45. [45]
    Kureha Corporation to Launch New Polyglycolic Acid (PGA ...
    Dec 18, 2007 · Kureha is the first and only company, which succeeded in developing technology to produce large volumes of PGA, supporting this development with ...
  46. [46]
    Kureha's Gamble - C&EN - American Chemical Society
    Apr 28, 2008 · The Japanese firm plans to spend $100 million on the world's first commercial-scale plant for polyglycolic acid.
  47. [47]
    Polyglycolic acid (PGA)Kuredux - KUREHA CORPORATION
    Kureha's PGA (polyglycolic acid) resin Kuredux offers advanced characteristics including, high strength and biodegradability.Missing: composites | Show results with:composites